Our Company

Our Story

Founded in 2008 by entrepreneurs, Jonathan O’Halloran and Elaine Warburton, QuantuMDx began in a garage laboratory in Sussex, UK. The company relocated to Cape Town, South Africa, supported by a £3 million grant to address diagnostic challenges in low-resource settings of disease areas, such as tuberculosis.

In 2011, QuantuMDx established laboratories in Newcastle-upon-Tyne, UK, securing £1.5 million from the National Institute for Health Research and £2.6 million from the European Union to accelerate development.

By 2015, the company had moved into purpose-built premises in Newcastle and co-founder, Jonathan O’Halloran, was awarded European Chief Technology Officer (CTO) of the Year.

QuantuMDx’s ongoing commitment to quality was recognised in 2018 with ISO 13485 certification.

During the COVID-19 pandemic in 2020, the team dedicated efforts to developing diagnostic products for SARS-CoV-2, driven by a strong sense of purpose and commitment to global health. Focused collaboration and robust operational support, including daily health checks, enabled the successful launch of the first generation of the Q-POC™ platform that same year.

In 2021, the Q-POC technology received a £15 million equity investment from Vita Spring to enhance its functionality and expand its multiplex testing capabilities.

In 2022, QuantuMDx entered a strategic cooperation agreement with Sansure Biotech Inc. (“Sansure”) to further develop global R&D. manufacturing and commercial partnerships, bringing a comprehensive array of innovative, high-performance molecular diagnostic assays to the Q-POC™ platform.

Our Core Belief

We believe that reliable testing should not be a luxury. It should be available to everyone, everywhere.

In many parts of the world, access to quality diagnostics is limited by geography, cost or infrastructure. We are committed to enabling everyone to have the chance to receive timely, accurate diagnoses, no matter where you live.

Since our founding in 2008, we have focused on making accessible testing for the most challenging environments. That means developing portable and user-friendly solutions that work at the point-of-need: in clinics, rural health posts or mobile units, so communities can get the answers they need, when they need them.

Equity in healthcare begins with access. We are making accessibility a real possibility.

Point-of-Care vs. Point-of-Need

At QuantuMDx, we understand that the need for rapid, reliable testing extends far beyond traditional care settings.

We are passionate about delivering diagnostics wherever they are most urgently needed, including remote, underserved or resource-limited environments that may lack formal healthcare structure. Our solutions are designed to be mobile, robust and self-contained, ensuring accurate testing can happen beyond the walls of traditional healthcare facilities, at the point-of-need.

Our Strategy

QuantuMDx recognise that not all healthcare providers have access to stable, well-equipped laboratory environments. We will continue to develop innovative diagnostic solutions that reduce strain on healthcare systems and enhance the patient experience.

Our diagnostics are designed to be decentralised: portable, easy to use and equipped with exceptional multiplex capability. By offering more answers from a single test, our technology supports more efficient and better-informed clinical decision-making.

We are continually expanding our test menu to address a broader range of healthcare needs, offering flexibility required for diverse and personalised applications across global healthcare systems.